DCLA
AGN

Douglas C. Lane & Associates’s Allergan Inc AGN Stock Holding History

Douglas C. Lane & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,690
Closed -$301K – 244
2014
Q3 		$301K Buy
+1,690
New +$281K 0.01% 190

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Douglas C. Lane & Associates's AGN Position: Q4 2014 in Review

Douglas C. Lane & Associates sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 1,690 shares — an estimated $301K sold.

Douglas C. Lane & Associates first reported a position in AGN in Q3 2014 and held it in 1 quarter. The position peaked at $301K in Q3 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Douglas C. Lane & Associates reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Douglas C. Lane & Associates sold 1,690 Allergan Inc shares in Q4 2014, an estimated $301K.
  • Douglas C. Lane & Associates first reported a position in Allergan Inc in Q3 2014 and held it in 1 quarter.
  • Douglas C. Lane & Associates's Allergan Inc position peaked at $301K in Q3 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2014, filed 21 Jan 2015.